Infirmary Health’s Heart & Vascular Institute performs first case using Optrell™ Mapping Catheter for the treatment of AFib

Pictured (L-R):  Joseph Brett (Biosense Webster); Jarrett Poiroux (Biosense Webster); Stephanie Lee, RCIS; Sherry Quick, RN; Dr. Andin Mullis; Stefanie Dunning, RN-Team Leader; Tyler Wesley (Biosense Webster); Mark Cauley (Biosense Webster)

Infirmary Health’s Heart & Vascular Institute is now providing leading edge treatment for atrial fibrillation (AFib) with the Optrell™ Mapping Catheter with TRUEref™ Technology from Biosense Webster. Dr. Andin Mullis, a cardiac electro-physiologist, performed the first Optrell catheter procedure across the Gulf Coast Region at Mobile Infirmary. This technology delivers high-resolution directional mapping of arrhythmias in any chamber guiding the physician to quickly and effectively identify ablation targets.

AFib is the most common type of cardiac arrhythmia, or abnormal heart rhythm, affecting more than 40 million people worldwide. During AFib, the atria beat in a rapid manner interrupting the flow of the heart’s electrical system causing ineffective blood flow. Left untreated, AFib can progressively get worse over time or lead to other serious complications like heart disease or stroke.

A catheter ablation is a safe and effective treatment method for patients with AFib. During an ablation, the heart’s incorrect electrical signals are restored correcting the signals that were causing the abnormal heart rhythm. A catheter ablation, typically performed by a electrophysiologist, can provide a patient with improved quality of life, symptom relief and elimination of long-term risk of stroke and heart attack.

If you have been diagnosed with or are experiencing the symptoms of AFib, ask your doctor about a referral to an electrophysiologist, a heart arrhythmia specialist. Learn more about Infirmary Health’s Heart & Vascular Institute and to find a cardiovascular specialist near you by visiting infirmaryhealth.org.